Amneal divests Creo PharmaZentiva has acquired Creo Pharmaceuticals from Amneal. Zydus Cadila gets FDA nod for generic LetairisAmbrisentan tablets had a market value of $943 million in 2018. Lupin debuts generic Lidex Fluocinonide ointment had a market value of roughly $15 million. Zydus launches generic Cialis Tadalafil tablets had a market value of $1.73 billion, according to January 2019 IQVIA data. Upsher-Smith launches generic Prozac Fluoxetine tablets had a market value of about $69 million for the 12 months ending December 2018. Dr. Reddy's launches generic Cialis The Cialis brand and generic had a market value of roughly $1.7 billion for the most recent 12 months ending January. Lupin gets FDA nod for generic Cialis Cialis had a market value of about $1.7 billion, according to December 2018 IQVIA data. Lannett gets FDA's blessing for generic Aggrenox Aggrenox capsules had a market value of roughly $174.6 million for the 12 months ended January 2019. Lupin launches generic Synthroid Levothyroxine sodium tablets had a market value of roughly $2.5 billion, according to January 2019 IQVIA data. FDA clears Lupin’s generic Viagra The erectile dysfunction treatment had a market value of $611 million, according to December 2018 IQVIA data. First Previous 194 195 196 197 198 Next Last
